Takashi Ninomiya

  • 345 Citations
  • 8 h-Index
20092019
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 30 Similar Profiles
Epidermal Growth Factor Receptor Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Mutation Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences
Lung Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

  • 345 Citations
  • 8 h-Index
  • 31 Article

Rapid and Long-term Response of Pulmonary Pleomorphic Carcinoma to Nivolumab

Senoo, S., Ninomiya, T., Makimoto, G., Nishii, K., Kano, H., Watanabe, H., Hata, Y., Kubo, T., Tanaka, T., Hotta, K., Maeda, Y. & Kiura, K., Apr 1 2019, In : Internal medicine (Tokyo, Japan). 58, 7, p. 985-989 5 p.

Research output: Contribution to journalArticle

Open Access
Cell Death
Carcinoma
Lung
Neoplasms
Macrophages
4 Citations (Scopus)

A phase I trial of afatinib and bevacizumab in chemo-naïve patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404

Ninomiya, T., Nogami, N., Kozuki, T., Harada, D., Kubo, T., Oohashi, K., Kuyama, S., Kudo, K., Bessho, A., Fukamatsu, N., Fujimoto, N., Aoe, K., Shibayama, T., Sugimoto, K., Takigawa, N., Hotta, K. & Kiura, K., Jan 1 2018, In : Lung Cancer. 115, p. 103-108 6 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Mutation
Diarrhea
1 Citation (Scopus)

Combined effect of cabozantinib and gefitinib in crizotinib-resistant lung tumors harboring ROS1 fusions

Kato, Y., Ninomiya, K., Oohashi, K., Tomida, S., Makimoto, G., Watanabe, H., Kudo, K., Matsumoto, S., Umemura, S., Goto, K., Ichihara, E., Ninomiya, T., Kubo, T., Sato, A., Hotta, K., Tabata, M., Toyooka, S., Maeda, Y. & Kiura, K., Jan 1 2018, (Accepted/In press) In : Cancer Science.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Lung
Protein-Tyrosine Kinases
Gene Fusion
Neoplasms
5 Citations (Scopus)
Epidermal Growth Factor Receptor
Mitogen-Activated Protein Kinase Kinases
Protein-Tyrosine Kinases
Therapeutics
osimertinib

Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol

Ninomiya, T., Ishikawa, N., Inoue, K., Kubo, T., Yasugi, M., Shibayama, T., Maeda, T., Fujitaka, K., Kodani, M., Yokoyama, T., Kuyama, S., Ochi, N., Ueda, Y., Miyoshi, S., Kozuki, T., Amano, Y., Kubota, T., Sugimoto, K., Bessho, A., Ishii, T. & 4 othersWatanabe, K., Oze, I., Hotta, K. & Kiura, K., Jan 1 2018, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Mutation
Disease-Free Survival
Protein-Tyrosine Kinases